White label ELPA - ClinicalTrials.eu

Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

Not recruiting

3 1 1 1
Investigated diseases:
- Influenza
Investigated drugs:
Study on the Effects of Yohimbine and Hydrocortisone on Stress and Moral Decisions in Military Personnel

Not recruiting

3 1 1
Investigated diseases:
- Anxiety
Investigated drugs:
Study on Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5-11

Not recruiting

1 1 1 1
Investigated drugs:
- GAXILOSE
Study on Apixaban for Preventing Blood Clots in Leg Veins During Long-Distance Flights for Travelers at Risk

Not recruiting

3 1 1
Investigated diseases:
- Deep vein thrombosis
Investigated drugs:
- Apixaban
Study on Lenacapavir for HIV Prevention in Individuals at Risk of HIV Infection

Not recruiting

4 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
Study on the Safety and Immune Response of BIMERVAX as a COVID-19 Booster in Adolescents Aged 12 to 17 Years

Not recruiting

2 1 1 1
Investigated diseases:
- COVID-19
Investigated drugs:
- SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER
Study on the Interaction Between Rivaroxaban and Sotorasib in Healthy Individuals

Not recruiting

3 1 1 1
Investigated drugs:
- Rivaroxaban
- Sotorasib
Study on Niraparib and Dostarlimab for Patients with DNA Repair-Deficient or Platinum-Sensitive Solid Tumors

Not recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Dostarlimab
- Niraparib
Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

Not recruiting

3 1 1 1
Investigated diseases:
- Respiratory syncytial virus bronchiolitis
- Respiratory syncytial virus infection
Investigated drugs:
- Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

Not recruiting

3 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies